Preliminary Outcomes in Care Partners of Patients receiving Lecanemab

Lecanemab infusions was well accepted in CP and PLWD with overall experience being positive following 3M infusions. Additionally, this did not add burden to CP. On-going data collection will provide further insights into CP outcomes.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_105196
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preliminary Outcomes in Care Partners of Patients receiving Lecanemab

Luke Conway, Leah R. Hanson, Marcel Hungs, Samantha J. Sherman et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Preliminary Outcomes in Care Partners of Patients receiving Lecanemab

Luke Conway, Leah R. Hanson, Marcel Hungs, Samantha J. Sherman, Clarissa M. Howe, Bhavani Kashyap, Lauryn E Jones
article en

Abstract

Lecanemab infusions was well accepted in CP and PLWD with overall experience being positive following 3M infusions. Additionally, this did not add burden to CP. On-going data collection will provide further insights into CP outcomes.

Alzheimer s & DementiaVol. 21(S5)
HealthPartners (US)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.